Primary lymphoma of bone
ICD-10 C85.7 · ICD-11 2B33.5&XA0UK0

Treatment of Primary Lymphoma of Bone in Children Under 18 with Critically Large Mediastinal Tumor and Respiratory Distress

Clinical Scenario

In a child or adolescent under 18 with suspected non-Hodgkin lymphoma, a critically large mediastinal tumor producing respiratory distress, severe respiratory insufficiency, or vena cava compression syndrome creates a life-threatening emergency that demands an immediate and unconventional management approach.

CRITICAL — Diagnostics Deferred
Key Constraint

Surgical intervention and invasive diagnostic procedures carry unacceptable risk in this setting. All further diagnostics — especially invasive procedures — must be deferred until clinical stabilization is achieved. Only a full blood count is obtained prior to initiating treatment.

Treatment Approach

Immediate cytoreductive therapy is begun without awaiting further diagnostic confirmation, using a corticosteroid as the core agent with a cytotoxic agent added if clinically required. The complete regimen, dosing strategy, and escalation criteria are detailed in the full protocol.

Treatment Goals

Rapid shrinking of the mediastinal tumor and clinical stabilization with resolution of respiratory distress, enabling safe progression to definitive diagnostic workup and treatment planning.

Instant Access to Structured Evidence-Based Regimens
References
  1. Patients with a critically large mediastinal tumor with clinical symptoms of respiratory distress should not be treated surgically and any distressing diagnostic procedure must be questioned depending on the clinical situation.
  2. If there is either severe respiratory insufficiency and/or vena cava compression syndrome all further diagnostics (except for blood tests), and especially invasive diagnostic procedures, should be postponed until clinical stabilization is achieved.
  3. In such a situation, cytoreductive therapy with prednisone and, if necessary, cyclophosphamide should be started immediately without any diagnostic procedure but a full blood count.
  4. Cytoreductive therapy with prednisone/prednisolone 60 mg/m²/d and/or cyclophosphamide 100 mg/m²/d should be started immediately. The dosage can be increased depending on clinical progress.
  5. Cytoreductive therapy with prednisone ± cyclophosphamide should be started immediately.
View source ↗